Author details

Full Name

Megan L Shaw

Affiliation

Icahn School of Medicine at Mount Sinai

ORCID

Career Start Year

2000

Papers

H Index

Expertise

CM4AI Collaborator

Trey Ideker (CM4AI)

PMID	Paper Title	Journal Title	Published Year
36959936	A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters.	Front Plant Sci	2023
37758692	Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.	Nat Commun	2023
37515096	LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters.	Viruses	2023
36197970	Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans.	Sci Adv	2022
33930332	Functional landscape of SARS-CoV-2 cellular restriction.	Mol Cell	2021
33558285	Enisamium Reduces Influenza Virus Shedding and Improves Patient Recovery by Inhibiting Viral RNA Polymerase Activity.	Antimicrob Agents Chemother	2021
33024967	Functional Landscape of SARS-CoV-2 Cellular Restriction.	bioRxiv	2020
30852344	Baloxavir marboxil: the new influenza drug on the market.	Curr Opin Virol	2019
31448902	An Influenza Virus Entry Inhibitor Targets Class II PI3 Kinase and Synergizes with Oseltamivir.	ACS Infect Dis	2019
28643205	Role of Host Genes in Influenza Virus Replication.	Curr Top Microbiol Immunol	2018
30146161	Transcription Elongation Can Affect Genome 3D Structure.	Cell	2018
29955068	Influenza.	Nat Rev Dis Primers	2018
30429226	Nucleolar Relocalization of RBM14 by Influenza A Virus NS1 Protein.	mSphere	2018
29391557	SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses.	Sci Rep	2018
29760472	Author Correction: SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses.	Sci Rep	2018
29321315	Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling.	J Virol	2018
29268608	Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein.	ACS Infect Dis	2018
28892353	The Next Wave of Influenza Drugs.	ACS Infect Dis	2017
25984567	A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein.	ACS Infect Dis	2015
26651948	Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding.	Cell Host Microbe	2015
26284260	High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus Replication.	ACS Infect Dis	2015
25972557	Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions.	J Virol	2015
24198417	Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.	J Virol	2014
23175362	A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant.	J Virol	2013
24035683	Successes and challenges in the antiviral field.	Curr Opin Virol	2013
23933115	New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.	Antiviral Res	2013
23487453	Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virus.	J Virol	2013
22577360	A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon.	PLoS Pathog	2012
23145065	Identification of small molecules with type I interferon inducing properties by high-throughput screening.	PLoS One	2012
21276872	Uncovering the global host cell requirements for influenza virus replication via RNAi screening.	Microbes Infect	2011
21823192	The host interactome of influenza virus presents new potential targets for antiviral drugs.	Rev Med Virol	2011
21436031	Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis.	Proc Natl Acad Sci U S A	2011
20027183	Human host factors required for influenza virus replication.	Nature	2010
20739535	Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study.	J Virol	2010
19211754	Nipah virus edits its P gene at high frequency to express the V and W proteins.	J Virol	2009
21994589	Henipaviruses employ a multifaceted approach to evade the antiviral interferon response.	Viruses	2009
19515782	Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism.	J Virol	2009
18041799	Aluminum triflate as a highly active and efficient nonprotic cocatalyst in the palladium-catalyzed methoxycarbonylation reaction.	Angew Chem Int Ed Engl	2008
18535660	Cellular proteins in influenza virus particles.	PLoS Pathog	2008
18585796	Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity.	Antiviral Res	2008
16698996	Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.	J Virol	2006
15857993	Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways.	J Virol	2005
15140960	Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively.	J Virol	2004
12502864	Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins.	J Virol	2003
12766998	Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins.	J Med Virol	2003
11023475	The amino acid sequence of the PKR-eIF2alpha phosphorylation homology domain of hepatitis C virus envelope 2 protein and response to interferon-alpha.	J Infect Dis	2000

1 - 46 of 46

Benjamin E Nilsson-Payant

Hanover Medical School

Career Start Year 2017

Number of shared co-authors 20

Adam Hage

University of Texas Medical Branch

Career Start Year 2017

Number of shared co-authors 4

Yushen Du

University of California los angeles

Career Start Year 2014

Number of shared co-authors 9

David Sachs

Icahn School of Medicine at Mount Sinai

Career Start Year 2013

Number of shared co-authors 14

James Zengel

Stanford University School of Medicine

Career Start Year 2010

Number of shared co-authors 6

Holly Ramage

Sidney Kimmel Medical College, Thomas Jefferson University

Career Start Year 2009

Number of shared co-authors 6

Carles Mart??nez-Romero

Icahn School of Medicine at Mount Sinai

Career Start Year 2009

Number of shared co-authors 21

Jennifer Tisoncik-Go

Center for Innate Immunity and Immune Disease, University of Washington

Career Start Year 2009

Number of shared co-authors 3

Colm Atkins

Rutgers University

Career Start Year 2007

Number of shared co-authors 4

Priya Luthra

Trudeau Institute

Career Start Year 2007

Number of shared co-authors 14

Amie J Eisfeld

Influenza Research Institute, University of Wisconsin-Madison

Career Start Year 2006

Number of shared co-authors 0

Nicholas S Heaton

Duke University School of Medicine

Career Start Year 2006

Number of shared co-authors 14

Chengjun Li

Harbin Veterinary Research Institute

Career Start Year 2005

Number of shared co-authors 3

Yaw Shin Ooi

Duke-NUS Medical School

Career Start Year 2003

Number of shared co-authors 4

Shirit Einav

Stanford University School of Medicine

Career Start Year 2002

Number of shared co-authors 3

Priya S Shah

University of California davis

Career Start Year 2002

Number of shared co-authors 18

Benjamin R tenOever

NYU Grossman School of Medicine

Career Start Year 2001

Number of shared co-authors 34

Birgit Bradel-Tretheway

Washington State University

Career Start Year 2000

Number of shared co-authors 1

Gaya K Amarasinghe

Washington University School of Medicine at St. Louis

Career Start Year 2000

Number of shared co-authors 9

Daisy W Leung

Washington University School of Medicine

Career Start Year 1999

Number of shared co-authors 8

Sonja M Best

National Institute of Allergy and Infectious Diseases, National Institutes of Health

Career Start Year 1998

Number of shared co-authors 6

Pei-Yong Shi

University of Texas Medical Branch

Career Start Year 1996

Number of shared co-authors 9

Ignacio Mena

Icahn School of Medicine at Mount Sinai

Career Start Year 1994

Number of shared co-authors 40

Ana Fernandez-Sesma

Icahn School of Medicine at Mount Sinai

Career Start Year 1993

Number of shared co-authors 39

Sara Cherry

University of Pennsylvania

Career Start Year 1993

Number of shared co-authors 12

Gabriele Neumann

Influenza Research Institute, University of Wisconsin-Madison

Career Start Year 1993

Number of shared co-authors 7

Michael Gale

Center for Innate Immunity and Immune Disease, University of Washington

Career Start Year 1988

Number of shared co-authors 5

Yoshihiro Kawaoka

Influenza Research Institute, University of Wisconsin

Career Start Year 1979

Number of shared co-authors 8

Michael G Katze

University of Washington

Career Start Year 1978

Number of shared co-authors 7

Georg Kochs

Institute of Virology, Freiburg University Medical Center, University of Freiburg

Career Start Year 1978

Number of shared co-authors 42

row(s) 1 - 30 of 30

Adolfo Garc??a-Sastre

Icahn School of Medicine at Mount Sinai

Co-authored papers 15

Peter Palese

Icahn School of Medicine at Mount Sinai

Co-authored papers 14

Lars Pache

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 9

Christopher F Basler

Icahn School of Medicine at Mount Sinai

Co-authored papers 8

Sumit K Chanda

The Scripps Research Institute

Co-authored papers 8

Silke Stertz

Institute of Medical Virology, University of Zurich

Co-authored papers 6

Kris M White

Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)

Co-authored papers 6

Paul D De Jesus

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 6

Judd F Hultquist

Northwestern University Feinberg School of Medicine

Co-authored papers 5

Laura Martin-Sancho

The Scripps Research Institute

Co-authored papers 4

Matthew Urbanowski

Icahn School of Medicine at Mount Sinai

Co-authored papers 4

Ariel Rodriguez-Frandsen

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 4

Nevan J Krogan (CM4AI)

University of California San Francisco

Co-authored papers 4

Randy A Albrecht

Icahn School of Medicine at Mount Sinai

Co-authored papers 3

Juan Ayllon

Icahn School of Medicine at Mount Sinai

Co-authored papers 3

Trey Ideker (CM4AI)

University of California San Diego

Co-authored papers 3

Hans-Heinrich Hoffmann

The Rockefeller University

Co-authored papers 3

Thibaut Vausselin

CNRS, INSERM, Institut Pasteur de Lille, Center for Infection and Immunity of Lille

Co-authored papers 3

Christopher Benner

Michigan State University College of Human Medicine

Co-authored papers 3

Mila B Ortigoza

NYU Grossman School of Medicine

Co-authored papers 3

Renate K??nig

Paul-Ehrlich-Institut

Co-authored papers 2

Dominik Dornfeld

Institute of Virology, Medical Center University of Freiburg

Co-authored papers 2

Daria Khokhlova-Cubberley

Co-authored papers 2

Hong M Moulton

Carlson College of Veterinary Medicine, Oregon State University

Co-authored papers 2

Martin Schwemmle

Institute of Virology, Medical Center - University of Freiburg

Co-authored papers 2

David A Stein

College of Veterinary Medicine, Oregon State University

Co-authored papers 2

Yap Ching Chew

Zymo Research Corporation

Co-authored papers 2

Sira C G??nther

Institute of Medical Virology, University of Zurichgrid.0.3

Co-authored papers 2

Atsushi Inoue

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 2

Giorgi Metreveli

Icahn School of Medicine at Mount Sinai

Co-authored papers 2

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators